Get the Stockscreener App
1.80
0.55%
-0.01
Caribou Biosciences Inc Stock (CRBU) Forecast
The Caribou Biosciences Inc (CRBU) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $7.1148, representing a +295.27% increase from the current price of $1.80. The highest analyst price target is $6.844, and the lowest is $7.3855.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CRBU Price Target
Average 6.1473
(+241.52% Upside)
Is Caribou Biosciences Inc (CRBU) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 38.70 | Neutral |
| STOCH(9,6) | 17.99 | Buy |
| STOCHRSI(14) | 9.9492 | Buy |
| MACD(12,26) | -0.0804 | Sell |
| ADX(14) | 16.65 | Neutral |
| William %R | -87.88 | Buy |
| CCI(14) | -92.71 | Neutral |
Buy: 3
Sell: 1
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.928
Sell
|
1.9072
Sell
|
| MA20 |
2.0202
Sell
|
1.9831
Sell
|
| MA50 |
2.08
Sell
|
2.0469
Sell
|
| MA100 |
2.0341
Sell
|
2.1937
Sell
|
| MA200 |
2.6707
Sell
|
2.8013
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, CRBU could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 11 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on CRBU, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 38.7 indicates that CRBU is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 17.99 indicates that CRBU is oversold. This indicates that CRBU price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 9.9492 indicates that CRBU is oversold. This suggests that CRBU price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 16.65 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -92.71 indicates that CRBU is still oversold but not to an extreme extent.
Long-term CRBU price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Caribou Biosciences Inc financial reports and earnings history, Caribou Biosciences Inc (CRBU) stock could reach $9.2133 by 2030, $98.40 by 2040 and $148.03 by 2050. See the projected annual prices until 2050 of the Caribou Biosciences Inc stock below:
- Caribou Biosciences Inc (CRBU) is expected to reach an average price of $42.73 in 2035, with a high prediction of $44.34 and a low estimate of $43.51. This indicates an $2,274% rise from the last recorded price of $1.80.
- Caribou Biosciences Inc (CRBU) stock is projected to chart a bullish course in 2040, with an average price target of $99.01, representing an $5,401% surge from its current level. The forecast ranges from a conservative $12.56 to a sky-high $98.40.
- Our analysts predict Caribou Biosciences Inc (CRBU) to jump 3,626% by 2045, soaring from $67.57 to an average price of $67.06, potentially reaching $67.75. While $67.57 is the low estimate, the potential upside is significant.
- Caribou Biosciences Inc (CRBU) stock is expected to climb by 2050, reaching an average of $145.48, a $7,982% jump from its current level. However, a wide range of estimates exists, with high and low targets of $148.03 and $145.61, respectively, highlighting the market's uncertainty.
Caribou Biosciences Inc Stock (CRBU) Year by Year Forecast
Caribou Biosciences Inc Stock (CRBU) Price Forecast for 2025
Caribou Biosciences Inc Stock (CRBU) is expected to reach an average price of $6.1473 in 2025, with a high prediction of $9.3068 and a low estimate of $2.9878. This indicates an +241.52% rise from the last recorded price of $1.80.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $7.3255 | $7.3855 | $6.844 | +306.97% |
| February, 2025 | $8.2908 | $7.3796 | $7.807 | +360.60% |
| March, 2025 | $7.3762 | $7.6962 | $7.9447 | +309.79% |
| April, 2025 | $9.5753 | $7.2676 | $8.4853 | +431.96% |
| May, 2025 | $7.9106 | $9.533 | $9.3068 | +339.48% |
| June, 2025 | $5.7259 | $6.4059 | $7.0545 | +218.11% |
| July, 2025 | $3.9001 | $4.1964 | $4.1698 | +116.67% |
| August, 2025 | $2.7704 | $2.9878 | $2.2004 | +53.91% |
| September, 2025 | $3.1257 | $3.0742 | $3.2219 | +73.65% |
| October, 2025 | $3.6149 | $3.0996 | $3.1349 | +100.83% |
| November, 2025 | $4.1802 | $3.1764 | $3.2902 | +132.23% |
| December, 2025 | $5.0193 | $4.7415 | $5.3779 | +178.85% |
Caribou Biosciences Inc Stock (CRBU) Price Forecast for 2026
The predicted value for Caribou Biosciences Inc (CRBU) in 2026 is set at an average of $2.8349. Estimates vary from a peak of $5.2515 to a trough of $0.4184, indicating an +57.50% surge from the present price of $1.80.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $4.2047 | $4.1674 | $3.9132 | +133.59% |
| February, 2026 | $4.45 | $4.4885 | $4.4761 | +147.22% |
| March, 2026 | $4.8253 | $5.5037 | $5.2515 | +168.07% |
| April, 2026 | $5.1644 | $4.9491 | $5.2106 | +186.91% |
| May, 2026 | $4.7698 | $5.0098 | $4.8071 | +164.99% |
| June, 2026 | $4.4251 | $4.6813 | $4.3151 | +145.84% |
| July, 2026 | $1.3942 | $1.9142 | $4.3189 | -22.54% |
| August, 2026 | $1.7095 | $1.2681 | $0.9395 | -5.03% |
| September, 2026 | $1.4087 | $1.6409 | $1.4217 | -21.74% |
| October, 2026 | $2.654 | $2.1025 | $2.209 | +47.45% |
| November, 2026 | $2.2393 | $2.9578 | $2.6855 | +24.41% |
| December, 2026 | $0.1985 | $0.4184 | $1.3332 | -88.97% |
Caribou Biosciences Inc Stock (CRBU) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Caribou Biosciences Inc (CRBU) is $11.89, with a high forecast of $23.76 and a low forecast of $0.0209. This indicates an +560.56% increase from the last price of $1.80.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.2662 | $0.1662 | $0.93 | -85.21% |
| February, 2027 | $0.4209 | $0.0209 | $0.7785 | -76.62% |
| March, 2027 | $2.4317 | $0.3671 | $2.5756 | +35.10% |
| April, 2027 | $1.2864 | $0.9064 | $3.9279 | -28.53% |
| May, 2027 | $0.5411 | $0.4611 | $1.7926 | -69.94% |
| June, 2027 | $16.85 | $0.2273 | $16.24 | +836.11% |
| July, 2027 | $10.25 | $13.55 | $13.14 | +469.48% |
| August, 2027 | $15.47 | $12.22 | $13.92 | +759.52% |
| September, 2027 | $16.20 | $17.77 | $17.47 | +799.98% |
| October, 2027 | $19.79 | $16.46 | $15.57 | +999.46% |
| November, 2027 | $20.82 | $20.33 | $18.36 | +1,057% |
| December, 2027 | $25.30 | $21.86 | $23.76 | +1,306% |
Caribou Biosciences Inc Stock (CRBU) Price Forecast for 2028
In 2028, Caribou Biosciences Inc (CRBU) is projected to reach an average price of $20.10, with a high projection of $24.32 and a low estimate of $15.89. This indicates an +1,017% rise from the last price of $1.80.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $24.00 | $24.13 | $24.32 | +1,233% |
| February, 2028 | $24.93 | $24.31 | $24.13 | +1,285% |
| March, 2028 | $23.58 | $23.78 | $23.67 | +1,210% |
| April, 2028 | $24.55 | $24.51 | $23.99 | +1,264% |
| May, 2028 | $22.56 | $22.81 | $23.28 | +1,153% |
| June, 2028 | $24.18 | $22.61 | $23.86 | +1,243% |
| July, 2028 | $22.03 | $23.03 | $24.11 | +1,124% |
| August, 2028 | $18.07 | $18.45 | $20.99 | +903.73% |
| September, 2028 | $15.81 | $17.43 | $17.02 | +778.21% |
| October, 2028 | $16.27 | $16.29 | $15.52 | +803.80% |
| November, 2028 | $16.03 | $15.89 | $16.22 | +790.38% |
| December, 2028 | $15.21 | $16.04 | $15.50 | +744.86% |
Caribou Biosciences Inc Stock (CRBU) Price Forecast for 2029
The 2029 price forecast for Caribou Biosciences Inc Stock (CRBU) is $13.04 on average, with a high prediction of $17.11 and a low estimate of $8.9674. This represents an +624.25% increase from the previous price of $1.80.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $17.18 | $15.22 | $17.11 | +854.21% |
| February, 2029 | $15.32 | $16.26 | $16.10 | +750.91% |
| March, 2029 | $14.91 | $15.26 | $14.85 | +728.17% |
| April, 2029 | $15.73 | $15.25 | $15.14 | +773.76% |
| May, 2029 | $15.27 | $14.98 | $15.49 | +748.11% |
| June, 2029 | $14.79 | $14.89 | $14.92 | +721.47% |
| July, 2029 | $13.36 | $13.79 | $14.20 | +642.07% |
| August, 2029 | $9.8255 | $13.07 | $13.07 | +445.86% |
| September, 2029 | $9.0461 | $9.3861 | $9.712 | +402.56% |
| October, 2029 | $9.2844 | $9.2944 | $8.8768 | +415.80% |
| November, 2029 | $9.235 | $8.9674 | $8.9028 | +413.06% |
| December, 2029 | $9.5657 | $9.5803 | $9.0857 | +431.43% |
Caribou Biosciences Inc Stock (CRBU) Price Forecast for 2030
Caribou Biosciences Inc Stock (CRBU) is expected to reach an average price of $18.91 in 2030, with a high forecast of $36.98 and a low forecast of $0.8418. This signifies an +950.52% surge from the last price of $1.80.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $7.194 | $8.709 | $9.2133 | +299.67% |
| February, 2030 | $5.7546 | $6.0446 | $6.2616 | +219.70% |
| March, 2030 | $5.8953 | $5.2849 | $4.8523 | +227.51% |
| April, 2030 | $3.7359 | $4.5659 | $4.7756 | +107.55% |
| May, 2030 | $0.8942 | $1.7942 | $2.8428 | -50.32% |
| June, 2030 | $2.7248 | $0.8418 | $2.1848 | +51.38% |
| July, 2030 | $3.1831 | $2.6925 | $2.7278 | +76.84% |
| August, 2030 | $35.21 | $2.8584 | $36.78 | +1,856% |
| September, 2030 | $31.18 | $32.23 | $33.36 | +1,632% |
| October, 2030 | $39.26 | $35.51 | $35.33 | +2,081% |
| November, 2030 | $34.72 | $35.51 | $36.74 | +1,829% |
| December, 2030 | $37.30 | $36.26 | $36.98 | +1,972% |
2.88%
2.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):